GRI Bio Presents Preclinical Data Demonstrating GRI-0621 Reduces The Important Inflammatory And Fibrotic Drivers In Idiopathic Pulmonary Fibrosis
Compared to controls, mice treated with GRI-0621 showed improved fibrosis and immunopathology; Inhibition of type 1 invariant Natural Killer T (iNKT) cell activity led to a decrease in fibrosis score and total lung